Rick joined Phlexglobal in April 2015 and is a CEO with a proven track record of successfully transforming solutions companies to higher growth, greater profitability and increased shareholder value. Rick has twenty-five plus years of increasing responsibilities with technology and professional services firms focused on meeting the needs of companies in the pharmaceutical and life sciences industries including positions as CEO, General Manager, and head of sales. Rick is known for building strong leadership teams and performance driven cultures. As the General Manager and then CEO of LIQUENT, he managed the divestiture of LIQUENT out of Thomson Reuters to Private Equity ownership, and after transforming the company to higher growth and profitability, led the sale of LIQUENT to PAREXEL, a large strategic buyer, which yielded almost six times net invested capital. After acquisition, Rick continued to lead the LIQUENT business through the successful integration into PAREXEL. Rick holds a Bachelor of Science from the Pennsylvania State University and a Masters of Business Administration from Villanova University.
Connect on LinkedIn